Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Last Updated: May 31, 2023

Investigational Drug Information for XP19986

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

What is the development status for investigational drug XP19986?

XP19986 is an investigational drug.

There have been 6 clinical trials for XP19986. The most recent clinical trial was a Phase 3 trial, which was initiated on May 1^st 2011.

The most common disease conditions in clinical trials are Gastroesophageal Reflux, Back Pain, and Spinal Cord Injuries. The leading clinical trial sponsors are Indivior Inc., XenoPort, Inc., and [disabled in preview].

Summary for XP19986

US Patents	0
International Patents	0
US Patent Applications	124
WIPO Patent Applications	50
Japanese Patent Applications	15
Clinical Trial Progress	Phase 3 (2011-05-01)
Vendors	15

Recent Clinical Trials for XP19986

Title	Sponsor	Phase
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis	Indivior Inc.	Phase 3
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis	XenoPort, Inc.	Phase 3
A Study to Evaluate the Efficacy and Safety of Arbaclofen Placarbil (XP19986) as Adjunctive Therapy in Subjects With Gastroesophageal Reflux Disease (GERD)	Indivior Inc.	Phase 2

See all XP19986 clinical trials

Clinical Trial Summary for XP19986

Top disease conditions for XP19986

Top clinical trial sponsors for XP19986

See all XP19986 clinical trials

US Patents for XP19986

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try a Trial
Drugname	Patent Number	Patent Title	Patent Assignee	Estimated Expiration
>Drugname	>Patent Number	>Patent Title	>Patent Assignee	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow

Johnson and Johnson

Baxter

AstraZeneca

Merck

Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.